How Shared Clinical Decision-Making Can Shape the Metastatic Prostate Cancer Journey - Fierce Healthcare
How Shared Clinical Decision-Making Can Shape the Metastatic Prostate Cancer Journey Fierce Healthcare
129 материалов по теме, собраны автоматически из проверенных источников
How Shared Clinical Decision-Making Can Shape the Metastatic Prostate Cancer Journey Fierce Healthcare
Подозревая рак простаты, мужчина с удивлением обнаружил, что ему требуется лишь медицинское лечение благодаря рентгеновскому снимку, сделанному три года назад. Vietnam.vn
“Missed Opportunity”: Real-World Outcomes Underscore Importance of Genomic Testing in Prostate Cancer Oncology News Central
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist or cardiologist improved cholesterol levels but did not lead to fewer heart attacks, strokes…
Use of active surveillance for early prostate cancer increased sharply in the VA healthcare system over the past couple decades, according to a research letter published in JAMA. Adoption of the approach tripled among men with low-risk prostate cancer and quadrupled among those with favorable intermediate-risk…
Statin therapy may attenuate much of the atherogenic effects associated with leuprolide for treatment of prostate cancer, according to a post hoc analysis of the REVELUTION trial published in JACC: CardioOncology. CVD is the leading cause of the death in men with prostate cancer, and adding statin therapy to…
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk prostate cancer indicate that SBRT improved bowel health-related quality of life…
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.